Imaging Biometrics Ltd.
IQAIF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -1.01% | -0.94% | -9.23% | 0.73% |
| EV / EBITDA | -134.91 | -342.59 | -12.69 | -25.30 |
| Quality | ||||
| ROIC | -8.73% | -8.73% | -63.42% | -117.10% |
| Gross Margin | 98.97% | 98.13% | 94.57% | 78.82% |
| Cash Conversion Ratio | 0.77 | 1.26 | 0.25 | -0.39 |
| Growth | ||||
| Revenue 3-Year CAGR | 21.87% | 32.12% | 51.36% | 62.30% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 2.89 | 5.25 | 0.74 | 0.54 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -24.41 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -21,054.24 | 97.18 | -2,344.18 | 38.59 |